We are live on ! Find out more
EFMH

E Fund Management (HK) Portfolio holdings

AUM $302M
1-Year Est. Return 64.42%
This Fund
S&P 500
This Quarter Est. Return
-1.42%
1 Year Est. Return
+64.42%
3 Year Est. Return
+162.67%
5 Year Est. Return
10 Year Est. Return
AUM
$220M
AUM Growth
-$77.6M
Cap. Flow
-$8.42M
Cap. Flow %
-3.83%
Top 10 Hldgs %
51.43%
Holding
506
New
110
Increased
201
Reduced
59
Closed
15

Top Sells

Rank Stock Value
1
ATO icon
Atmos Energy
ATO
+$5.47M
2
NEM icon
Newmont
NEM
+$3.12M
3
AEM icon
Agnico Eagle Mines
AEM
+$2.78M
4
AAPL icon
Apple
AAPL
+$2.17M
5
B
Barrick Mining
B
+$2.14M

Sector Composition

Rank Sector Weight
1 Technology 25.42%
2 Consumer Discretionary 23.57%
3 Communication Services 10.84%
4 Materials 9.73%
5 Consumer Staples 3.48%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
AJG icon
226
Arthur J. Gallagher & Co
AJG
$64.1B
$16.7K 0.01%
77
+75
+3,750% +$17.3K
MSI icon
227
Motorola Solutions
MSI
$72.3B
$16.5K 0.01%
38
+36
+1,800% +$15.6K
PTGX icon
228
Protagonist Therapeutics
PTGX
$8.79B
$16.4K 0.01%
+156
New +$13.8K
TGTX icon
229
TG Therapeutics
TGTX
$7.96B
$16.3K 0.01%
+492
New +$14.7K
BBIO icon
230
BridgeBio Pharma
BBIO
$15.7B
$16.3K 0.01%
+220
New +$15.9K
TDG icon
231
TransDigm Group
TDG
$70.2B
$16.2K 0.01%
+14
New +$18.4K
MMM icon
232
3M
MMM
$90.9B
$16K 0.01%
110
+106
+2,650% +$16.9K
CB icon
233
Chubb
CB
$135B
$16K 0.01%
49
+46
+1,533% +$14.8K
DE icon
234
Deere & Co
DE
$160B
$15.8K 0.01%
28
+26
+1,300% +$14.7K
CGON icon
235
CG Oncology
CGON
$6.28B
$15.8K 0.01%
+233
New +$13.2K
CYTK icon
236
Cytokinetics
CYTK
$10.5B
$15.8K 0.01%
+239
New +$15.2K
SHW icon
237
Sherwin-Williams
SHW
$82.7B
$15.7K 0.01%
49
+47
+2,350% +$16.2K
SRRK icon
238
Scholar Rock
SRRK
$5.67B
$15.6K 0.01%
+318
New +$14.3K
PPG icon
239
PPG Industries
PPG
$24.6B
$15.6K 0.01%
+146
New +$16.6K
PTCT icon
240
PTC Therapeutics
PTCT
$5.68B
$15.6K 0.01%
+229
New +$16.2K
SNY icon
241
Sanofi
SNY
$103B
$15.6K 0.01%
+323
New +$15.1K
MIRM icon
242
Mirum Pharmaceuticals
MIRM
$6.46B
$15.4K 0.01%
+167
New +$15.7K
C icon
243
Citigroup
C
$222B
$15.3K 0.01%
135
-1,810
-93% -$206K
WELL icon
244
Welltower
WELL
$169B
$15.2K 0.01%
77
+73
+1,825% +$14.4K
PH icon
245
Parker-Hannifin
PH
$123B
$15.2K 0.01%
17
+16
+1,600% +$15.1K
RPRX icon
246
Royalty Pharma
RPRX
$25.9B
$15.2K 0.01%
+317
New +$13.9K
ABT icon
247
Abbott
ABT
$183B
$15.2K 0.01%
148
+137
+1,245% +$15.5K
ARWR icon
248
Arrowhead Research
ARWR
$11.9B
$15.1K 0.01%
+241
New +$15.3K
ERAS icon
249
Erasca
ERAS
$6.3B
$15.1K 0.01%
+932
New +$11K
AXSM icon
250
Axsome Therapeutics
AXSM
$11.2B
$15K 0.01%
+89
New +$15.4K

Similar funds

E Fund Management (HK)'s Q1 2026 Portfolio in Review

As of Q1 2026, E Fund Management (HK) held 506 positions worth $220M, down 26% from $297M the previous quarter. Its ten largest holdings account for 51% of the portfolio.

E Fund Management (HK) withdrew a net $8.42M in Q1 2026, closing 15 positions and reducing 59 holdings. Its most notable exit was Qfin Holdings, an estimated $636K position sold in full.

By sector, the portfolio is most concentrated in Technology at 25% of assets, up from 19% a quarter earlier, followed by Consumer Discretionary and Communication Services.

Against the trend, E Fund Management (HK) opened a new position in AngloGold Ashanti worth $1.73M.

  • E Fund Management (HK)'s largest Q1 2026 buy was AngloGold Ashanti: 17,747 shares worth $1.73M.
  • E Fund Management (HK) added most to iShares Core S&P 500 ETF in Q1 2026, an estimated $2.07M increase.
  • E Fund Management (HK)'s biggest Q1 2026 reduction was Atmos Energy, cutting an estimated $5.47M.
  • E Fund Management (HK) fully exited Qfin Holdings in Q1 2026, selling an estimated $636K.
  • E Fund Management (HK)'s ten largest holdings make up 51% of its $220M portfolio in Q1 2026.
  • E Fund Management (HK) opened 110 new positions and closed 15 in Q1 2026.
  • E Fund Management (HK)'s portfolio value fell 26% quarter-over-quarter to $220M.

Based on E Fund Management (HK)'s 13F filing for Q1 2026, filed 8 Apr 2026.